Dr. László Tabár

Clinical News
Opinion: Stop misleading women on breast screening
The article published 5 July by JAMA Oncology about the cost-effectiveness of breast screening is another example of the type of "nonscience" from a leading tabloid journal, writes Dr. László Tabár. Women and decision-makers deserve correct and honest information, and it's time to focus on the harm of not being screened, he notes.
July 5, 2018
2018 05 09 16 47 3984 Tabar Lazlo Thumb
Clinical News
Mammography's alleged harms: Separating fact from fiction
Screening mammography is a tool that has been proved to reduce breast cancer death rates, but its effectiveness continues to be disputed by researchers, some of whom have resorted to guesswork to buttress their arguments, according to an opinion piece by mammography experts Dr. László Tabár and Dr. Peter B. Dean.
December 13, 2012
2012 12 12 12 51 12 319 Tabar Lazslo Thumb
Clinical News
Analysis of Swedish county data is off the mark
In this week's study in the Journal of the National Cancer Institute, a research team claimed to find that mammography screening had no impact on mortality from breast cancer, based on their interpretation of data from Swedish counties. However, the group made a number of fatal mistakes in their analysis, according to Dr. László Tabár.
July 16, 2012
2012 07 17 13 48 49 867 Second Opinion Eu
Page 1 of 1
Top Stories
Isotopes1
Nuclear Medicine
Telix signs agreement to acquire ITM
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
Screenshot 2026 09 21 202952
Nuclear Medicine
Sustainability in cancer care: from machines to systems
Photo illustrating eco-responsibility, a theme that the SFR continues to champion at the JFR. The photograph shows a paper flower made by a patient (www.poeticmood.fr) who will be running craft workshops at the Patient Associations’ Village during JFR 2026. Participants will be invited to create their own JFR 2026 flower and take it home.
Organized Radiology Issues
Les patients d’abord! Patients first at this year’s JFR meeting
Whats App Image 2026 09 17 At 15 24 59
Nuclear Medicine
IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?
From left: moderator Christine Mhundwa with Dr. Claudio Tinoco Mesquita, Dr. Ariel Fariña Barrios, Dr. Dina Husseiny Salama, Dr. Umesh Mahantshetty, Dr. Ellen Kampman and Dr. Alejandro Mazal.
Nuclear Medicine
Radiation medicine aims to tackle cancer care inequalities in low-income countries
More in Home
Telix signs agreement to acquire ITM
By Erik L. Ridley
The deal would create a combined company with significant radioisotope manufacturing, distribution, and radiopharmaceutical development capabilities.
September 21, 2026
Isotopes1
Sustainability in cancer care: from machines to systems
By Claudia Tschabuschnig
Speakers at a session at the IAEA Scientific Forum asked what remains after the machine has been installed.
September 21, 2026
Screenshot 2026 09 21 202952
Les patients d’abord! Patients first at this year’s JFR meeting
By Frances Rylands-Monk
JFR president Prof. Isabelle Thomassin-Naggara discusses the importance of the human radiologist for patients, a key theme at this year’s congress.
September 18, 2026
Photo illustrating eco-responsibility, a theme that the SFR continues to champion at the JFR. The photograph shows a paper flower made by a patient (www.poeticmood.fr) who will be running craft workshops at the Patient Associations’ Village during JFR 2026. Participants will be invited to create their own JFR 2026 flower and take it home.
IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?
By Claudia Tschabuschnig
Research promising one-second treatment planning prompted discussion of workforce shortages and delays in cancer care at the IAEA Scientific Forum in Vienna.
September 17, 2026
Whats App Image 2026 09 17 At 15 24 59
Radiation medicine aims to tackle cancer care inequalities in low-income countries
By Claudia Tschabuschnig
Health experts discussed challenges facing cancer care in low income countries, the potential of theranostics as well as AI, covering various topics to bridge global health disparities at the IAEA Scientific Forum in Vienna.
September 16, 2026
From left: moderator Christine Mhundwa with Dr. Claudio Tinoco Mesquita, Dr. Ariel Fariña Barrios, Dr. Dina Husseiny Salama, Dr. Umesh Mahantshetty, Dr. Ellen Kampman and Dr. Alejandro Mazal.
IAEA Scientific Forum: Where you live should not determine access to cancer care
By Claudia Tschabuschnig
At the IAEA Scientific Forum in Vienna, politicians, health policymakers, ministers, and physicians came with a bunch of numbers on the stark differences in access to radiotherapy, nuclear medicine, and medical imaging, especially in low and middle income countries.
September 15, 2026
Whats App Image 2026 09 15 At 20 00 14
CIRSE: Studies link ablation margins to liver tumor control
By Claudia Tschabuschnig
Two studies presented at CIRSE 2026 linked adequate ablation margins to better liver tumor control. Measuring those margins consistently remains a challenge.
September 14, 2026
Gonnie van Erp: “We still see interobserver differences in margin assessment.”
ESHNR 2026 spotlights salivary gland perfusion and neck cyst origins
By Claudia Tschabuschnig
The society honoured Tim Beale and supported the next generation of radiologists at ESHNR 2026 in Budapest.
September 14, 2026
Img 7948
From the reading room to the front line and back to the saddle
By Oleksandr Berezovskyi
A radiologist's ride from Ukraine to Berlin.
September 11, 2026
U Kr6
Radical radiotherapy use rising for treating lung cancer
By Amerigo Allegretto
Radical radiotherapy use nearly doubled between 2010 and 2021 in lung cancer patients and correlates to improved five-year outcomes.
September 10, 2026
Lungs Red 400
CIRSE: Should drug-coated devices remain routine in leg artery treatment?
By Claudia Tschabuschnig
Could SWEDEPAD, two Swedish trials comparing drug-coated and uncoated devices for leg artery treatment, change practice? CIRSE experts debated patient benefits and long-term safety.
September 10, 2026
CIRSE 2026
CIRSE’s ‘Amazing Interventions’ go beyond conventional routes
By Claudia Tschabuschnig
From creating new biliary pathways to targeting elusive lymphatic leaks, specialists at CIRSE 2026 shared inventive interventions for patients with few remaining options.
September 9, 2026
Endovascular splenorenal shunt in chronic portal vein thrombosis presented by Dr. Carolin Sobotta University Medicine Goettingen Goettingen, Germany
Page 1 of 92
Next Page